DAE HWA Pharmaceutical Co. Ltd Cash Flow-to-Debt Ratio
DAE HWA Pharmaceutical Co. Ltd cash flow-to-debt ratio. DAE HWA Pharmaceutical Co. Ltd (067080) has a Cash Flow-to-Debt Ratio of -0.01x as of June 2026, meaning its operating cash flow of ₩-1.72 Billion could theoretically repay 0% of its total liabilities (₩134.61 Billion) in one year. Check DAE HWA Pharmaceutical Co. Ltd (067080) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of DAE HWA Pharmaceutical Co. Ltd (2011–2025)
Cash flow-to-debt ratio of DAE HWA Pharmaceutical Co. Ltd from 2011 to 2025. Historical debt coverage capacity for DAE HWA Pharmaceutical Co. Ltd across 15 annual periods. Check cash flow quality index of DAE HWA Pharmaceutical Co. Ltd to evaluate the quality of earnings relative to operating cash generation.
DAE HWA Pharmaceutical Co. Ltd Cash Flow-to-Debt Ratio by Year (2011–2025)
DAE HWA Pharmaceutical Co. Ltd cash flow-to-debt ratio by year from 2011 to 2025. Year-by-year debt coverage analysis for DAE HWA Pharmaceutical Co. Ltd. For the full cash flow conversion analysis, see cash flow conversion of DAE HWA Pharmaceutical Co. Ltd.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.04x | ₩5.43 Billion | ₩131.72 Billion | ▼ -9.9% |
| 2024 | 0.05x | ₩6.13 Billion | ₩133.89 Billion | ▲ +1231.3% |
| 2023 | 0.00x | ₩-590.27 Million | ₩145.93 Billion | ▼ -106.1% |
| 2022 | 0.07x | ₩8.05 Billion | ₩121.06 Billion | ▼ -37.8% |
| 2021 | 0.11x | ₩10.45 Billion | ₩97.70 Billion | ▲ +243.1% |
| 2020 | 0.03x | ₩2.90 Billion | ₩93.07 Billion | ▲ +6686.3% |
| 2019 | 0.00x | ₩-41.07 Million | ₩86.80 Billion | ▼ -100.4% |
| 2018 | 0.12x | ₩10.49 Billion | ₩85.17 Billion | ▼ -0.2% |
| 2017 | 0.12x | ₩10.94 Billion | ₩88.72 Billion | ▲ +23.0% |
| 2016 | 0.10x | ₩8.79 Billion | ₩87.65 Billion | ▲ +162.2% |
| 2015 | 0.04x | ₩2.43 Billion | ₩63.55 Billion | ▼ -59.4% |
| 2014 | 0.09x | ₩6.18 Billion | ₩65.57 Billion | ▼ -58.4% |
| 2013 | 0.23x | ₩13.57 Billion | ₩59.84 Billion | ▲ +170.4% |
| 2012 | 0.08x | ₩5.77 Billion | ₩68.80 Billion | ▲ +92.2% |
| 2011 | 0.04x | ₩3.43 Billion | ₩78.60 Billion | — |